Moderna, Inc. (MRNA) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $20.6 billion, Moderna, Inc. is a large-cap company. The stock currently trades at $52.84, down 1.35% today, with a 52-week range of $22.28–$55.20.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-7.26 | $-7.26 | +21.8% | |
| 2024 | $-9.28 | $-9.28 | +24.7% | |
| 2023 | $-12.33 | $-12.33 | -161.3% | |
| 2022 | $20.12 | $21.26 | -28.9% | |
| 2021 | $28.29 | $30.31 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-20 | 0001682852-26-000033 | SEC ↗ |
| 2024-12-31 | 2025-02-21 | 0001682852-25-000022 | SEC ↗ |
| 2023-12-31 | 2024-02-23 | 0001682852-24-000015 | SEC ↗ |
| 2022-12-31 | 2023-02-24 | 0001682852-23-000011 | SEC ↗ |
| 2021-12-31 | 2022-02-25 | 0001682852-22-000012 | SEC ↗ |
| 2020-12-31 | 2021-02-26 | 0001682852-21-000006 | SEC ↗ |